Loading clinical trials...
Loading clinical trials...
Adoptive Immunotherapy for Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell
Conditions
Interventions
CD19-TriCAR-T/SILK
Locations
1
China
Hunan Provincial People's Hospital
Changsha, Hunan, China
Start Date
March 21, 2019
Primary Completion Date
April 15, 2022
Completion Date
October 15, 2022
Last Updated
September 6, 2019
NCT00106925
NCT06311227
NCT07388563
NCT06285890
NCT07350863
NCT06220162
Lead Sponsor
Timmune Biotech Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions